InterHem Poradnie Specjalistyczne
- Address
- lock Available on a paid plan
InterHem Poradnie Specjalistyczne - Musculoskeletal Research Center
InterHem Poradnie Specjalistyczne is a specialized medical research center focused on advancing treatments for musculoskeletal disorders. The center demonstrates particular expertise in conducting clinical trials for inflammatory conditions affecting the shoulder and upper extremity, contributing valuable research data to improve patient outcomes in orthopedic care.
- Rotator cuff tendinopathy treatment studies
- Biologic therapies for musculoskeletal inflammation
- Novel therapeutic interventions for shoulder disorders
The research team at InterHem specializes in evaluating innovative biologic agents for the treatment of moderate to severe tendinopathies. Their clinical trial portfolio includes studies examining subcutaneous therapeutic interventions aimed at improving physical function and reducing inflammatory symptoms in patients with chronic shoulder conditions, positioning the center as a key contributor to evidence-based musculoskeletal medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Kartos Therapeutics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in InterHem Poradnie Specjalistyczne
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficacy and safety of secukinumab compared to placebo in adult patients with active rotator cuff tendinopathy | Novartis Pharma AG | Phase III | Not Recruiting | Oct 2023 | Dec 2024 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Loperamide Hydrochloride | 1 | Unknown | 2024-10-16 | 2024-10-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.